Compare · CRWD vs SNCE
CRWD vs SNCE
Side-by-side comparison of CrowdStrike Holdings Inc. (CRWD) and Science 37 Holdings Inc. (SNCE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CRWD and SNCE operate in Computer Software: Prepackaged Software (Technology), so they compete in similar markets.
- CRWD is the larger of the two at $215.05B, about 233.5x SNCE ($921.1M).
- CRWD has hit the wire 42 times in the past 4 weeks while SNCE has been quiet.
- CRWD has more recent analyst coverage (25 ratings vs 5 for SNCE).
- Company
- CrowdStrike Holdings Inc.
- Science 37 Holdings Inc.
- Price
- $207.96-1.01%
- $5.75+0.17%
- Market cap
- $215.05B
- $921.1M
- 1M return
- -7.78%
- -
- 1Y return
- +96.10%
- -
- Industry
- Computer Software: Prepackaged Software
- Computer Software: Prepackaged Software
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- 2020
- News (4w)
- 42
- 0
- Recent ratings
- 25
- 5
CrowdStrike Holdings Inc.
CrowdStrike Holdings, Inc. provides cloud-delivered solutions for endpoint and cloud workload protection in the United States, Australia, Germany, India, Israel, Romania, and the United Kingdom. It offers 19 cloud modules on its Falcon platform through a software as a service subscription-based model that covers various security markets, such as corporate workload security, security and vulnerability management, managed security services, IT operations management, threat intelligence services, identity protection, and log management. The company primarily sells its platform and cloud modules through its direct sales team. CrowdStrike Holdings, Inc. was incorporated in 2011 and is headquartered in Sunnyvale, California.
Latest CRWD
- Wipro and CrowdStrike Launch CISO Command Center to Transform Enterprise Cybersecurity Operations
- PRESIDENT AND CEO Kurtz George sold $4,164,832 worth of shares (20,000 units at $208.24), decreasing direct ownership by 0.26% to 7,816,019 units (SEC Form 4)
- VAST Data and CrowdStrike Deliver First-of-Its-Kind Cybersecurity Across the AI Operating System
- PRESIDENT AND CEO Kurtz George sold $4,456,066 worth of shares (20,000 units at $222.80), decreasing direct ownership by 0.25% to 7,836,019 units (SEC Form 4)
- Director Gandhi Sameer K sold $4,337,534 worth of shares (20,000 units at $216.88) as part of a pre-agreed trading plan (SEC Form 4)
- CrowdStrike Announces 2026 Customer and Partner Award Winners: The Leaders Securing the Front Lines of AI
- CrowdStrike Brings the Falcon Platform to the Anthropic Claude Marketplace
- CrowdStrike Unveils the Next Evolution of the Agentic SOC
- Introducing the CrowdStrike Agentic Identity Provider, the Foundation for AI Agent Identity Security
- CrowdStrike Extends Its Endpoint Advantage to Secure the Software Supply Chain
Latest SNCE
- Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial
- Science 37 and Catalent Announce Partnership Enabling Universal Access to Clinical Research
- Science 37 Completes Second FDA Inspection as Enrollment Leader in Phase 3 Asthma Trial
- Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation
- Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial
- Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC
- Science 37 Enrolls 42% of Trial Cohort in 8 Weeks
- Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials
- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial
- Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance